Obesity is an Independent Risk Factor for Cancer Development Following Diagnosis of Dermatomyositis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Obesity is an Independent Risk Factor for Cancer Development Following Diagnosis of Dermatomyositis
Authors
Keywords
-
Journal
SEMINARS IN ARTHRITIS AND RHEUMATISM
Volume -, Issue -, Pages 152283
Publisher
Elsevier BV
Online
2023-11-04
DOI
10.1016/j.semarthrit.2023.152283
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Systematic Review and Meta-Analysis to Inform Cancer Screening Guidelines in Idiopathic Inflammatory Myopathies
- (2021) Alexander G S Oldroyd et al. RHEUMATOLOGY
- Validation of obesity‐related diagnosis codes in claims data
- (2021) Karine Suissa et al. DIABETES OBESITY & METABOLISM
- Methods to Analyze Time-to-Event Data: The Cox Regression Analysis
- (2021) Samar Abd ElHafeez et al. Oxidative Medicine and Cellular Longevity
- Incidence of different cancer types in dermatomyositis, polymyositis and dermatopolymyositis: results of a registry analysis
- (2020) M. Zidane et al. BRITISH JOURNAL OF DERMATOLOGY
- Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms
- (2020) Christine M. Friedenreich et al. Molecular Oncology
- Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: a 25-year retrospective study
- (2019) Kyoko Motomura et al. RHEUMATOLOGY INTERNATIONAL
- Age‐ and sex‐appropriate cancer screening risks missing most occult malignancies in young patients with dermatomyositis
- (2019) A. Kundrick et al. BRITISH JOURNAL OF DERMATOLOGY
- Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer
- (2018) Megan A. Clarke et al. JOURNAL OF CLINICAL ONCOLOGY
- The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositis
- (2018) Alexander Oldroyd et al. RHEUMATOLOGY
- Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study
- (2017) John Svensson et al. RHEUMATOLOGY
- Validation of International Classification of Diseases Codes for the Epidemiologic Study of Dermatomyositis
- (2017) Michael C. Kwa et al. ARTHRITIS CARE & RESEARCH
- Risk of Malignancy in Dermatomyositis and Polymyositis
- (2016) Judy K. Qiang et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Cancer Risk in Dermatomyositis: A Meta-Analysis of Cohort Studies
- (2015) Jeannette M. Olazagasti et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort
- (2015) Gerd Cecilie Dobloug et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins
- (2011) Manabu Fujimoto et al. ARTHRITIS AND RHEUMATISM
- Idiopathic Inflammatory Myopathy Associated with Malignancy: A Retrospective Cohort of 151 Korean Patients with Dermatomyositis and Polymyositis
- (2011) M. W. SO et al. JOURNAL OF RHEUMATOLOGY
- Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan
- (2010) Yi-Ju Chen et al. ARTHRITIS RESEARCH & THERAPY
- Obesity and Mammography: A Systematic Review and Meta-Analysis
- (2009) Nisa M. Maruthur et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Malignancy Is Associated with Dermatomyositis But Not Polymyositis in Northern New England, USA
- (2009) B. B. ANTIOCHOS et al. JOURNAL OF RHEUMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started